Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

COVID-19

Free Subscription 09.02.2026 1 Antiviral Res 1 BMJ 1 Clin Infect Dis 8 Int J Infect Dis 1 J Med Virol 1 J Travel Med 1 J Virol 2 JAMA 2 Science

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Antiviral Res

1. YURGELONIS I, Rai DK, Li Z, Washington B, et al
   Analysis of Ibuzatrelvir's Activity Against SARS-CoV-2 Circulating Variants and In Vitro Resistance Mutations.
   Antiviral Res. 2026 Jan 30:106352. doi: 10.1016/j.antiviral.2026.106352.
   PubMed         Abstract available
   
   

   
   BMJ

2. LEI Z
   Reduced disease detection during covid-19.
   BMJ. 2026;392:s236.
   PubMed        
   
   

   
   Clin Infect Dis

3. MA KC, Surie D, Dean N, Paden CR, et al
   Integrating genomic data into test-negative designs for estimating lineage-specific COVID-19 vaccine effectiveness.
   Clin Infect Dis. 2026 Feb 2:ciag059. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Int J Infect Dis

4. MICHELI G, Mondi A, Roen A, Taramasso L, et al
   Did the COVID-19 pandemic shift the landscape of late HIV diagnosis?
   Int J Infect Dis. 2026 Jan 28:108437. doi: 10.1016/j.ijid.2026.108437.
   PubMed         Abstract available
   
   
5. RUTHRICH MM, Schmitt T, Classen AY, Brandt J, et al
   Seasonal Community-Acquired Respiratory Virus Infections in Patients with Cancer - Epidemiological and Clinical Overview, an Analysis of the Multicenter OncoReVir Registry.
   Int J Infect Dis. 2026 Jan 29:108421. doi: 10.1016/j.ijid.2026.108421.
   PubMed         Abstract available
   
   
6. KIM HK, Jin Y, Lee J, Kim YM, et al
   Facility-specific epidemiological characteristics of COVID-19 clusters across SARS-CoV-2 variant waves in South Korea.
   Int J Infect Dis. 2026 Feb 1:108450. doi: 10.1016/j.ijid.2026.108450.
   PubMed         Abstract available
   
   
7. HO YC, Wang YT, Chou SH, Yu Liu S, et al
   Clinical outcomes of immunocompromised patients administered tixagevimab-cilgavimab as pre-exposure prophylaxis for COVID-19: real-world experience in Taiwan.
   Int J Infect Dis. 2026 Feb 2:108455. doi: 10.1016/j.ijid.2026.108455.
   PubMed         Abstract available
   
   
8. GUO YX, Yang RX, Li SS, Liang B, et al
   Associations of C-reactive protein-albumin-lymphocyte (CALLY) index with severity and prognosis in COVID-19 patients.
   Int J Infect Dis. 2026 Feb 2:108459. doi: 10.1016/j.ijid.2026.108459.
   PubMed         Abstract available
   
   
9. OGOTI B, Riitho V, Wildemann J, Mutono N, et al
   Epidemiology and genomic features of MERS coronavirus in Africa: a systematic and meta-analysis review.
   Int J Infect Dis. 2026 Feb 3:108456. doi: 10.1016/j.ijid.2026.108456.
   PubMed         Abstract available
   
   
10. KAWASHIMA A, Tsuchiya K, Kuroki K, Nagashima M, et al
    Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Intra-host Viral Evolution in a Severely Immunocompromised Patient with Human Immunodeficiency Virus Infection: A Whole-Genome Sequencing Study.
    Int J Infect Dis. 2026 Feb 3:108453. doi: 10.1016/j.ijid.2026.108453.
    PubMed         Abstract available
    
    
11. MASANGKAY CB, Vinarao JG, Malbas FF Jr, Quinones GJD, et al
    Comparative Evaluation of SARS-CoV-2 Antigens as Capture and Detection Elements in an In-House Antigen-Based ELISA for COVID-19 Total Antibody Detection.
    Int J Infect Dis. 2026 Feb 4:108461. doi: 10.1016/j.ijid.2026.108461.
    PubMed         Abstract available
    
    

    
    J Med Virol

12. KIM J, Park H, Chua HK, Wang Y, et al
    Comparing Cross-Sectional and Longitudinal Study Designs for Accurate Viral Dynamics Estimation: Insights From the NBA Cohort Data.
    J Med Virol. 2026;98:e70823.
    PubMed         Abstract available
    
    

    
    J Travel Med

13. AL-ANSARI F, Al Ansari M, Rashid H, Al-Ansari B, et al
    Facemask use at the Arbaeen Mass Gathering during and after COVID-19 pandemic: a naked eye survey.
    J Travel Med. 2026 Jan 30:taag010. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Virol

14. YAO Q, Mahase V, Hou W, Cruz-Cosme R, et al
    Computational and experimental identification of potential neutralizing peptides derived from human ACE2 against SARS-CoV-2 infection.
    J Virol. 2026 Jan 30:e0146825. doi: 10.1128/jvi.01468.
    PubMed         Abstract available
    
    

    
    JAMA

15. ANDERER S
    US Skilled Nursing Facility Capacity Fell 5% Since COVID-19 Pandemic.
    JAMA. 2026 Jan 30. doi: 10.1001/jama.2025.26365.
    PubMed        
    
    
16. ABBASI J
    Mechanisms Are Emerging for COVID-19 Vaccine-Associated Myocarditis.
    JAMA. 2026 Feb 6. doi: 10.1001/jama.2025.25866.
    PubMed        
    
    

    
    Science

17. BLOOMFIELD D, Black JRM, Crook O, Brandes N, et al
    Biological data governance in an age of AI.
    Science. 2026;391:558-561.
    PubMed         Abstract available
    
    
18. NISBET EG, Manning MR
    What is causing the methane surge?
    Science. 2026;391:556-557.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO COVID-19 is free of charge.